This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Colmegna, I.
Right arrow Articles by Espinoza, L. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Colmegna, I.
Right arrow Articles by Espinoza, L. R.

 Previous Article  |  Next Article 

Clinical Microbiology Reviews, April 2004, p. 348-369, Vol. 17, No. 2
0893-8512/04/$08.00+0     DOI: 10.1128/CMR.17.2.348-369.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

HLA-B27-Associated Reactive Arthritis: Pathogenetic and Clinical Considerations

Inés Colmegna, Raquel Cuchacovich, and Luis R. Espinoza*

Section of Rheumatology, Department of Medicine, LSU Health Science Center, New Orleans, Louisiana 70112

Current evidence supports the concept that reactive arthritis (ReA) is an immune-mediated synovitis resulting from slow bacterial infections and showing intra-articular persistence of viable, nonculturable bacteria and/or immunogenetic bacterial antigens synthesized by metabolically active bacteria residing in the joint and/or elsewhere in the body. The mechanisms that lead to the development of ReA are complex and basically involve an interaction between an arthritogenic agent and a predisposed host. The way in which a host accommodates to invasive facultative intracellular bacteria is the key to the development of ReA. The details of the molecular pathways that explain the articular and extra-articular manifestations of the disease are still under investigation. Several studies have been done to gain a better understanding of the pathogenesis of ReA; these constitute the basis for a more rational therapeutic approach to this disease.

* Corresponding author. Mailing address: LSU Medical Center, 1542 Tulane Ave., New Orleans, LA 70112. Phone: (504) 568-4630. Fax: (504) 568-4642. E-mail: luisrolan{at}msn.com.

Clinical Microbiology Reviews, April 2004, p. 348-369, Vol. 17, No. 2
0893-8512/04/$08.00+0     DOI: 10.1128/CMR.17.2.348-369.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Kuuliala, K., Orpana, A., Leirisalo-Repo, M., Repo, H. (2007). Neutrophils of healthy subjects with a history of reactive arthritis show enhanced responsiveness, as defined by CD11b expression in adherent and non-adherent whole blood cultures. Rheumatology (Oxford) 46: 934-937 [Abstract] [Full Text]  
  • Anttonen, K, Orpana, A, Leirisalo-Repo, M, Repo, H (2006). Aberrant TNF secretion by whole blood in healthy subjects with a history of reactive arthritis: time course in adherent and non-adherent cultures. Ann Rheum Dis 65: 372-378 [Abstract] [Full Text]  
  • Rawlins, M. L., Gerstner, C., Hill, H. R., Litwin, C. M. (2005). Evaluation of a Western Blot Method for the Detection of Yersinia Antibodies: Evidence of Serological Cross-Reactivity between Yersinia Outer Membrane Proteins and Borrelia burgdorferi. CVI 12: 1269-1274 [Abstract] [Full Text]  
  • Schmidt-Ott, R., Brass, F., Scholz, C., Werner, C., Gross, U. (2005). Improved serodiagnosis of Campylobacter jejuni infections using recombinant antigens. J Med Microbiol 54: 761-767 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»